Supplementary Table S1 from A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid CancerSophie Leboulleux,Christine Do Cao,Slimane Zerdoud,Marie Attard,Claire Bournaud,Ludovic Lacroix,Danielle Benisvy,David Taïeb,Stéphane Bardet,Marie Terroir-Cassou-Mounat,Nadège Anizan,Emilie Bouvier-Morel,Livia Lamartina,Georges Lion,Sarah Betrian,Christophe Sajous,Aurélie Schiazza,Marie-Eve Garcia,Renaud Ciappuccini,Martin Schlumberger,Abir Al Ghuzlan,Yann Godbert,Isabelle Borgetcrossref(2023)引用 0|浏览18暂无评分摘要Representativeness of Study Participants更多查看译文AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要